Ingredient Safety Concerns Rise Among FDA Enforcement Priorities
This article was originally published in The Tan Sheet
Executive Summary
Ingredient safety, new dietary ingredient notifications, adverse event reporting, claims substantiation and disease claims are all drawing FDA attention in the supplement space, Daniel Fabricant says. Compliance for good manufacturing practices still heads the priorities for enforcement, he says.
You may also be interested in...
Medical Foods No “Dumping Ground” For Disease Claims – FDA
FDA’s Dan Fabricant warns placing a medical food label on a dietary supplement constrained by structure/function claims does not make disease claims for the product legal. He says the agency is cracking down on products mislabeled as medical foods and on medical foods making disease claims.
Medical Foods No “Dumping Ground” For Disease Claims – FDA
FDA’s Dan Fabricant warns placing a medical food label on a dietary supplement constrained by structure/function claims does not make disease claims for the product legal. He says the agency is cracking down on products mislabeled as medical foods and on medical foods making disease claims.
In Brief: FDA responds to Nasacort suit, acts on acetaminophen and continues medical food enforcement
FDA responds to Nasacort Allergy suit; FDA will act on lower acetaminophen dose; FDA warns consumers about wart removers; FDA continues medical food enforcement; Supplements must include declared ingredients; CHPA applauds DXM-related legislation; and USP opens Shanghai facility.